Y Mabs Therapeutics Stock Price on December 2, 2024
| YMAB Stock | USD 10.28 0.02 0.19% |
Below is the normalized historical share price chart for Y mAbs Therapeutics extending back to September 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Y MAbs stands at 10.28, as last reported on the 11th of December 2024, with the highest price reaching 10.66 and the lowest price hitting 10.21 during the day.
If you're considering investing in YMAB Stock, it is important to understand the factors that can impact its price. Y mAbs Therapeutics shows Sharpe Ratio of -0.0811, which attests that the company had a -0.0811% return per unit of risk over the last 3 months. Y mAbs Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Y MAbs' Standard Deviation of 3.88, mean deviation of 2.66, and Market Risk Adjusted Performance of (0.20) to validate the risk estimate we provide.
At present, Y MAbs' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 150.1 M, whereas Common Stock Total Equity is forecasted to decline to 3,667. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.19, whereas Price To Sales Ratio is forecasted to decline to 3.33. YMAB Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of September 2018 | 200 Day MA 13.5018 | 50 Day MA 13.2034 | Beta 0.671 |
YMAB |
Sharpe Ratio = -0.0811
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | YMAB |
Estimated Market Risk
| 3.97 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Y MAbs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Y MAbs by adding Y MAbs to a well-diversified portfolio.
Price Book 4.9718 | Enterprise Value Ebitda (0.43) | Price Sales 5.4455 | Shares Float 27.3 M | Wall Street Target Price 20.6364 |
Related Headline
Revolution Medicines Headline on 2nd of December 2024
Revolution Medicines Provides Clinical Updates from its RAS ... by finance.yahoo.com
Compelling Phase 11b update on RMC-6236 monotherapy in second-line metastatic pancreatic ductal adenocarcinoma supports ongoing Phase 3 RASolute 302 clinical trial Phase 11b proof-of-concept for RMC-6236 monotherapy in previously treated non-small cell lung cancer supports Phase 3 RASolve 301 clinical trial expected to be initiated in Q1 2025 Favorable initial safety profile for combination of pembrolizumab with either RMC-6236 or RMC-6291 supports continued evaluation in non-small cell lung c
Y MAbs Valuation on December 2, 2024
It is possible to determine the worth of Y MAbs on a given historical date. On December 2, 2024 YMAB was worth 11.93 at the beginning of the trading date compared to the closed value of 11.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Y MAbs stock. Still, in general, we apply an absolute valuation method to find Y MAbs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Y MAbs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Y MAbs' related companies.
| Open | High | Low | Close | Volume | |
| 11.88 | 12.39 | 11.75 | 11.92 | 187,182 | |
12/02/2024 | 11.93 | 11.93 | 11.29 | 11.79 | 181,061 |
| 11.73 | 11.81 | 10.55 | 10.57 | 252,305 |
| Backtest Y MAbs | | | Y MAbs History | | | Y MAbs Valuation | Previous | Next |
Y MAbs Trading Date Momentum on December 2, 2024
| On December 03 2024 Y mAbs Therapeutics was traded for 10.57 at the closing time. The top price for the day was 11.81 and the lowest listed price was 10.55 . The trading volume for the day was 252.3 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 10.35% . The trading price change against the current closing price is 13.40% . |
Y mAbs Therapeutics Fundamentals Correlations and Trends
By evaluating Y MAbs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Y MAbs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. YMAB financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Y MAbs Stock history
Y MAbs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for YMAB is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Y mAbs Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Y MAbs stock prices may prove useful in developing a viable investing in Y MAbs
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43.6 M | 41.4 M | |
| Net Loss | -86 M | -90.3 M |
Y MAbs Quarterly Net Working Capital |
|
Y MAbs Stock Technical Analysis
Y MAbs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Y MAbs Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Y mAbs Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Y MAbs December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Y MAbs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Y MAbs shares will generate the highest return on investment. By undertsting and applying Y MAbs stock market strength indicators, traders can identify Y mAbs Therapeutics entry and exit signals to maximize returns
Y MAbs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Y MAbs' price direction in advance. Along with the technical and fundamental analysis of YMAB Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of YMAB to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for YMAB Stock analysis
When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |